FDAHealthJanuary 29, 2026
Teva Pharmaceuticals USA, Inc — Metoprolol Succinate Extended-Release Tablets, 50 mg, 100 tablets bottles (NDC: 45963-676-11) and 1,000 tablets bottles (NDC: 45963-676-96), Rx Only, Teva Pharmaceutica
⚠️ Failed Dissolution Specifications
Is this relevant to me?
- Geography
- Nationwide
- Source agency
- FDA
- Category
- Health
- Published
- January 29, 2026
Nationwide
What's affected?
- Product
- Metoprolol Succinate Extended-Release Tablets, 50 mg, 100 tablets bottles (NDC: 45963-676-11) and 1,000 tablets bottles (NDC: 45963-676-96), Rx Only, Teva Pharmaceuticals, Parsippany, NJ 07054
- Brand
- METOPROLOL SUCCINATE
- Lot code
- a)
Additional details
Lot#: a) 0486G251, 0487G251, 0488G251, Exp.: 01/2027; b) 0486G252, 0487G253, 0488G252, Exp.: 01/2027.
What should I do?
Recommended action
Class II recall. Voluntary: Firm initiated Quantity affected: 67,043 bottles.
Get Health recall alerts
Delivered to your inbox. Free. No account required.